Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
7 studies found for:    Open Studies | "Raynaud Disease"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Raynaud Disease"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Diosmiplex (Vasculera®) in Primary and Secondary Raynaud's Phenomenon
Condition: Raynaud's Disease
Interventions: Other: placebo;   Dietary Supplement: diosmiplex
2 Recruiting PORH and Response to Cold in Raynaud's Phenomenon.
Conditions: Raynaud Disease;   Hyperemia;   Cold
Interventions: Procedure: post-occlusive hyperemia;   Procedure: cooling box;   Drug: L-NMMA and Fluconazole dermic injection
3 Not yet recruiting Treatment of Digital Ulcers in Korean Patients With Systemic Sclerosis: a Prospective Cohort Study
Conditions: Raynaud Disease;   Systemic Sclerosis;   Digital Ulcer
Interventions: Drug: Calcium Channel Blockers;   Drug: Phosphodiesterase Inhibitors;   Drug: Endothelin receptor blocker;   Drug: Prostanoids;   Drug: Other vasodilator
4 Recruiting Assess Efficacy of of Oral Treprostinil in Patients With Symptomatic Primary or Secondary Raynaud's Phenomenon
Condition: Raynaud's Phenomenon
Interventions: Drug: oral treprostinil;   Drug: Placebo
5 Not yet recruiting Prospective Multicenter Study on the Identification of Genetic Abnormalities Predisposing to Vasospasm From a Privileged Model: the Primary Raynaud's Phenomenon
Conditions: Primary Raynaud's Phenomenon (PR);   Genetic Mutations Causing PR;   Study of Patients and Their Relatives (With or Without Primary PR)
Intervention: Genetic: Demonstration of genetic mutations causing Raynaud's phenomenon
6 Not yet recruiting Efficacy and Safety of Vascana® in Subjects With Secondary Raynaud's Phenomenon
Condition: Raynaud's Phenomenon Secondary to Connective Tissue Disease
Interventions: Drug: Vascana (0.9% nitroglycerin cream);   Drug: Vehicle (placebo)
7 Not yet recruiting Safety and Efficacy Study of Gene Therapy Drug (Neovasculgen) to Treat Secondary Raynaud's Phenomenon
Condition: Secondary Raynaud's Phenomenon
Intervention: Drug: Neovasculgen

Study has passed its completion date and status has not been verified in more than two years.